Guo J.-YJEN-CHIH CHENChen C.-Y.2022-04-252022-04-25202117264901https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103683957&doi=10.1097%2fJCMA.0000000000000512&partnerID=40&md5=f9d0acbe8f0360cca358fba0db35c023https://scholars.lib.ntu.edu.tw/handle/123456789/606162anakinrabiological markercytokeratin 18ghrelininterleukin 1betainterleukin 2 receptor alphainterleukin 2adaptive immunityantifibrotic activitybariatric surgeryCD4+ T lymphocyteCD8+ T lymphocytecell activationcross-sectional studycytokine releasediabetes mellitusdrug safetyEditorialfatty liver indexhepatic stellate cellhumaninflammationinflammatory cellinsulin releaseliver biopsyliver fibrosismetabolic fatty livermorbid obesitynonalcoholic fatty liverpancreas islet beta cellprospective studyprotein blood levelmetabolic syndrome XmetabolismpathophysiologyBiomarkersHumansInterleukin-2Metabolic SyndromeNon-alcoholic Fatty Liver Disease[SDGs]SDG3[SDGs]SDG17Is there any useful surrogate to evaluate metabolic fatty liver disease?editorial10.1097/JCMA.0000000000000512337429912-s2.0-85103683957